Preeclampsia continues to afflict 5% to 8% of all pregnancies throughout the world and is
associated with significant morbidity and mortality to the mother and the fetus. Although the …

Preeclampsia is a leading cause of pregnancy-related morbidity and mortality in the United
States. In the past 30 years, a large amount of research has been performed to investigate …

The root cause of preeclampsia is the placenta. Preeclampsia begins to abate with the
delivery of the placenta and can occur in the absence of a fetus but with the presence of …

Preeclampsia, a hypertensive disorder peculiar to pregnancy, is a systemic syndrome that
appears to originate in the placenta and is characterized by widespread maternal …

Intrauterine growth restriction (IUGR) remains one of the main challenges in maternity care.
Improvements have to start from a better definition of IUGR, applying the concept of the fetal …

The aim of this study was to investigate cardiac functional status in pregnancy using a
comprehensive approach taking into account the simultaneous changes in loading and …

Fetal intrauterine growth restriction presents a complex management problem for the
clinician. The failure of a fetus to achieve its growth potential imparts a significantly …

Because early and late preeclampsia (PE) are thought to be different disease entities, we
compared maternal cardiac function at 24 weeks gestation in a group of normotensive …

Introduction. Accumulating evidence suggests that an imbalance between pro-angiogenic
(ie, vascular endothelial growth factor (VEGF) and placental growth factor (PlGF)) and anti …

Objective: Preeclampsia (PE) has been classified into early-and late-onset disease. These
two phenotypic variants of PE have been proposed to have a different pathophysiology …